Skye Bioscience, Inc. Increase (Decrease) in Accounts Receivable
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Accounts Receivable of $1.19 thousand for the 9-month period ending 2014-07-31, per its 10-Q filed 2014-09-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2014-09-15
- Skye Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2014-07-31 was -$8.90K.
- Skye Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2014-04-30 was $623.00, a 94.04% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2014-01-31 was $9.46K, a 35.73% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accounts receivable for the quarter ending 2013-10-31 was -$3.33K.
- Skye Bioscience, Inc. increase (decrease) in accounts receivable for fiscal 2013 was $18.43K, a 166.90% increase from fiscal 2012.
- Skye Bioscience, Inc. increase (decrease) in accounts receivable for fiscal 2012 was $6.91K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 25 month | Increase (Decrease) in Accounts Receivable 29 month |
|---|---|---|---|---|---|---|---|
| 2014-07-31 | -$8.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | -$8.27K derived: sum of 2 quarters · filed 2014-09-15 | $1.19K 10-Q · filed 2014-09-15 | -$2.14K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2014-04-30 | $623.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | $10.09K 10-Q · filed 2014-06-05 | $6.76K derived: sum of 3 quarters · filed 2014-06-05 | $3.35K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2014-01-31 | $9.46K 10-Q · filed 2014-03-17 | $6.14K derived: sum of 2 quarters · filed 2014-03-17 | $2.72K derived: sum of 3 quarters · filed 2014-09-15 | $13.17K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2013-10-31 | -$3.33K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | -$6.74K derived: sum of 2 quarters · filed 2014-09-15 | $3.71K derived: sum of 3 quarters · filed 2014-09-15 | $18.43K 10-K · filed 2014-01-27 | |||
| 2013-07-31 | -$3.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $7.03K derived: sum of 2 quarters · filed 2014-09-15 | $21.76K 10-Q · filed 2014-09-15 | $28.67K 10-Q · filed 2013-09-16 | |||
| 2013-04-30 | $10.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | $25.17K 10-Q · filed 2014-06-05 | -$25.17K 10-Q · filed 2013-06-27 | -$32.08K 10-Q · filed 2013-06-27 | |||
| 2013-01-31 | $14.73K 10-Q · filed 2014-03-17 | ||||||
| 2012-10-31 | $6.91K 10-K · filed 2014-01-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |